Status:
UNKNOWN
Does Immunotherapy Have a Role in the Management of Endometriosis?
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
Endometriosis
Eligibility:
FEMALE
Brief Summary
Pathological specimens of 40 women that had been operated for endometriosis will be included in this study. These tissues will be stained with a marker named as PDL-1 in pathological examination. "pro...
Detailed Description
40 women who had been operated for endometriosis between 2013 and 2014 will be included in this study. Pathological specimens will be stained with an immunohistochemical marker named as PDL-1. "progra...
Eligibility Criteria
Inclusion
- patients operated for endometriosis between 2013 and 2014
- pathological examinations proving the diagnosis of endometriosis
Exclusion
- patients operated for cysts other than endometriosis
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03464799
Start Date
September 1 2018
End Date
December 1 2018
Last Update
August 14 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.